25I-NBOMe: Difference between revisions

>Josikins
>Unity
Placed SummarySheet above SubstanceBox.
Line 1: Line 1:
{{Headerpanel|{{Warning/25I-NBOMe}}}}
{{Headerpanel|{{Warning/25I-NBOMe}}}}
{{SummarySheet}}
{{SubstanceBox/25I-NBOMe}}
{{SubstanceBox/25I-NBOMe}}
{|
 
|-
|-
| ''[[25I-NBOMe/Summary|Summary sheet: 25I-NBOMe]]''
|}
'''25I-NBOMe''' (also known as '''2C-I-NBOMe''', '''Cimbi-5''' and '''N-Bomb''', although this term might also include other members of the [[25x-NBOMe]] family) is novel synthetic [[Psychoactive class::psychedelic]] of the [[chemical class::Phenethylamine|substituted phenethylamine]] that produces [[Visual effects - Psychedelics|visual-dominant psychedelic effects]] when [[Routes of administration|administered]]. 25I-NBOMe, short-hand for 2C-I-NBOMe, is a derivative of [[2C-I]], first synthesized and documented in 2003 by Ralf Heim at the Free University of Berlin,<ref name="Ralf Heim PhD. (2010-02-28)">Ralf Heim PhD. (2010-02-28) "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts." | http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221 (in German). diss.fu-berlin.de. Retrieved 2013-05-10.</ref> and subsequently investigated by a team at Purdue University led by psychedelics chemist and researcher [[David E. Nichols|David Nichols]].<ref name="Michael Robert Braden PhD. (2007)">Michael Robert Braden PhD. (2007). "Towards a biophysical understanding of hallucinogen action." | http://proquest.umi.com/pqdlink?Ver=1&Exp=01-23-2014&FMT=7&DID=1417800971&RQT=309&attempt=1&cfc=1 Purdue University. Retrieved 2012-08-08.</ref>  
'''25I-NBOMe''' (also known as '''2C-I-NBOMe''', '''Cimbi-5''' and '''N-Bomb''', although this term might also include other members of the [[25x-NBOMe]] family) is novel synthetic [[Psychoactive class::psychedelic]] of the [[chemical class::Phenethylamine|substituted phenethylamine]] that produces [[Visual effects - Psychedelics|visual-dominant psychedelic effects]] when [[Routes of administration|administered]]. 25I-NBOMe, short-hand for 2C-I-NBOMe, is a derivative of [[2C-I]], first synthesized and documented in 2003 by Ralf Heim at the Free University of Berlin,<ref name="Ralf Heim PhD. (2010-02-28)">Ralf Heim PhD. (2010-02-28) "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts." | http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221 (in German). diss.fu-berlin.de. Retrieved 2013-05-10.</ref> and subsequently investigated by a team at Purdue University led by psychedelics chemist and researcher [[David E. Nichols|David Nichols]].<ref name="Michael Robert Braden PhD. (2007)">Michael Robert Braden PhD. (2007). "Towards a biophysical understanding of hallucinogen action." | http://proquest.umi.com/pqdlink?Ver=1&Exp=01-23-2014&FMT=7&DID=1417800971&RQT=309&attempt=1&cfc=1 Purdue University. Retrieved 2012-08-08.</ref>